143 related articles for article (PubMed ID: 26294003)
1. Abnormalities in Plasma Phospholipid Fatty Acid Profiles of Patients with Hepatocellular Carcinoma.
Qiu JF; Zhang KL; Zhang XJ; Hu YJ; Li P; Shang CZ; Wan JB
Lipids; 2015 Oct; 50(10):977-85. PubMed ID: 26294003
[TBL] [Abstract][Full Text] [Related]
2. Characterizing plasma phospholipid fatty acid profiles of polycystic ovary syndrome patients with and without insulin resistance using GC-MS and chemometrics approach.
Zhang XJ; Huang LL; Su H; Chen YX; Huang J; He C; Li P; Yang DZ; Wan JB
J Pharm Biomed Anal; 2014 Jul; 95():85-92. PubMed ID: 24637052
[TBL] [Abstract][Full Text] [Related]
3. Fatty acid composition of the erythrocyte membrane and risk of hepatocellular carcinoma in cirrhotic patients.
Mouillot T; Rizk M; Pais de Barros JP; Gilloteau A; Busson A; Bernard-Chabert B; Thiefin G; Barraud H; Bronowicki JP; Richou C; Di Martino V; Doffoel M; Minello A; Latournerie M; Jouve JL; Brondel L; Brindisi MC; Petit JM; Hillon P; Cottet V;
Aliment Pharmacol Ther; 2020 Nov; 52(9):1503-1515. PubMed ID: 32780481
[TBL] [Abstract][Full Text] [Related]
4. Arachidonic acid in mononuclear cells and its clinical significance in HCV cirrhotic patients.
Okita M; Tomioka K; Ota Y; Sasagawa T; Osawa T; Sakai N; Kawaguchi M; Itoshima T
Nutrition; 2003 Sep; 19(9):727-32. PubMed ID: 12921881
[TBL] [Abstract][Full Text] [Related]
5. NMR and LC/MS-based global metabolomics to identify serum biomarkers differentiating hepatocellular carcinoma from liver cirrhosis.
Liu Y; Hong Z; Tan G; Dong X; Yang G; Zhao L; Chen X; Zhu Z; Lou Z; Qian B; Zhang G; Chai Y
Int J Cancer; 2014 Aug; 135(3):658-68. PubMed ID: 24382646
[TBL] [Abstract][Full Text] [Related]
6. Glutathione species and metabolomic prints in subjects with liver disease as biological markers for the detection of hepatocellular carcinoma.
Sanabria JR; Kombu RS; Zhang GF; Sandlers Y; Ai J; Ibarra RA; Abbas R; Goyal K; Brunengraber H
HPB (Oxford); 2016 Dec; 18(12):979-990. PubMed ID: 28340971
[TBL] [Abstract][Full Text] [Related]
7. Identification of potential erythrocyte phospholipid fatty acid biomarkers of advanced lung adenocarcinoma, squamous cell lung carcinoma, and small cell lung cancer.
Sánchez-Rodríguez P; Rodríguez MC; Sánchez-Yagüe J
Tumour Biol; 2015 Jul; 36(7):5687-98. PubMed ID: 25702090
[TBL] [Abstract][Full Text] [Related]
8. Serum lipidomic profiling as a useful tool for screening potential biomarkers of hepatitis B-related hepatocellular carcinoma by ultraperformance liquid chromatography-mass spectrometry.
Passos-Castilho AM; Carvalho VM; Cardozo KH; Kikuchi L; Chagas AL; Gomes-Gouvêa MS; Malta F; de Seixas-Santos Nastri AC; Pinho JR; Carrilho FJ; Granato CF
BMC Cancer; 2015 Dec; 15():985. PubMed ID: 26680993
[TBL] [Abstract][Full Text] [Related]
9. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma.
Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z
Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839
[TBL] [Abstract][Full Text] [Related]
10. Circulating microRNA-200 Family as Diagnostic Marker in Hepatocellular Carcinoma.
Dhayat SA; Hüsing A; Senninger N; Schmidt HH; Haier J; Wolters H; Kabar I
PLoS One; 2015; 10(10):e0140066. PubMed ID: 26447841
[TBL] [Abstract][Full Text] [Related]
11. Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography-mass spectrometry.
Wang B; Chen D; Chen Y; Hu Z; Cao M; Xie Q; Chen Y; Xu J; Zheng S; Li L
J Proteome Res; 2012 Feb; 11(2):1217-27. PubMed ID: 22200553
[TBL] [Abstract][Full Text] [Related]
12. TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
Mao L; Wang Y; Wang D; Han G; Fu S; Wang J
PLoS One; 2017; 12(9):e0183880. PubMed ID: 28902891
[TBL] [Abstract][Full Text] [Related]
13. Plasma miR-15b-5p, miR-338-5p, and miR-764 as Biomarkers for Hepatocellular Carcinoma.
Chen Y; Chen J; Liu Y; Li S; Huang P
Med Sci Monit; 2015 Jun; 21():1864-71. PubMed ID: 26119771
[TBL] [Abstract][Full Text] [Related]
14. Serum Metabolomics to Identify the Liver Disease-Specific Biomarkers for the Progression of Hepatitis to Hepatocellular Carcinoma.
Gao R; Cheng J; Fan C; Shi X; Cao Y; Sun B; Ding H; Hu C; Dong F; Yan X
Sci Rep; 2015 Dec; 5():18175. PubMed ID: 26658617
[TBL] [Abstract][Full Text] [Related]
15. Correlation between serum phospholipid fatty acids and dietary intakes assessed a few years earlier.
Thiébaut AC; Rotival M; Gauthier E; Lenoir GM; Boutron-Ruault MC; Joulin V; Clavel-Chapelon F; Chajès V
Nutr Cancer; 2009; 61(4):500-9. PubMed ID: 19838922
[TBL] [Abstract][Full Text] [Related]
16. Plasma protein biomarkers of hepatocellular carcinoma in HCV-infected alcoholic patients with cirrhosis.
Ferrín G; Rodríguez-Perálvarez M; Aguilar-Melero P; Ranchal I; Llamoza C; Linares CI; González-Rubio S; Muntané J; Briceño J; López-Cillero P; Montero-Álvarez JL; de la Mata M
PLoS One; 2015; 10(3):e0118527. PubMed ID: 25789864
[TBL] [Abstract][Full Text] [Related]
17. Plasma microRNA might as a potential biomarker for hepatocellular carcinoma and chronic liver disease screening.
Jiang L; Li X; Cheng Q; Zhang BH
Tumour Biol; 2015 Sep; 36(9):7167-74. PubMed ID: 25894380
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of prothrombin induced by vitamin K absence, macrophage migration inhibitory factor and Golgi protein-73 versus alpha fetoprotein for hepatocellular carcinoma diagnosis and surveillance.
Ismail MM; Morsi HK; Abdulateef NA; Noaman MK; Abou El-Ella GA
Scand J Clin Lab Invest; 2017 May; 77(3):175-183. PubMed ID: 28276727
[TBL] [Abstract][Full Text] [Related]
19. Prediagnostic alterations in circulating bile acid profiles in the development of hepatocellular carcinoma.
Stepien M; Lopez-Nogueroles M; Lahoz A; Kühn T; Perlemuter G; Voican C; Ciocan D; Boutron-Ruault MC; Jansen E; Viallon V; Leitzmann M; Tjønneland A; Severi G; Mancini FR; Dong C; Kaaks R; Fortner RT; Bergmann MM; Boeing H; Trichopoulou A; Karakatsani A; Peppa E; Palli D; Krogh V; Tumino R; Sacerdote C; Panico S; Bueno-de-Mesquita HB; Skeie G; Merino S; Ros RZ; Sánchez MJ; Amiano P; Huerta JM; Barricarte A; Sjöberg K; Ohlsson B; Nyström H; Werner M; Perez-Cornago A; Schmidt JA; Freisling H; Scalbert A; Weiderpass E; Christakoudi S; Gunter MJ; Jenab M
Int J Cancer; 2022 Apr; 150(8):1255-1268. PubMed ID: 34843121
[TBL] [Abstract][Full Text] [Related]
20. Altered plasma and erythrocyte phospholipid fatty acid profile in elite female water polo and football players.
Arsić A; Vučić V; Tepšić J; Mazić S; Djelić M; Glibetić M
Appl Physiol Nutr Metab; 2012 Feb; 37(1):40-7. PubMed ID: 22165902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
